Minimally invasive TAVI helps avoid high-risk surgery and associated complications
FACTS Foundation, a non-profit organisation of cardiologists and cardiac surgeons, committed to newer research, innovation, education, and training; in association with Apollo Hospitals, Hyderabad, hosted a one-day interactive workshop ‘TAVI saves lives – TAVI for life.’ The workshop was inaugurated by cardiac valve disease patients, two of whom were aged 90 years each and an 80-year-old, all of whom are leading a normal life after being treated with Trans Aortic Valve Implantation (TAVI). TAVI is a great new advancement in the therapy for needy elderly patients who are suffering from calcific aortic valve disease.
The workshop was attended by over two hundred cardiologists from across both the Telugu states and over 1000 others through online live streaming. It focussed on the latest advances in cardiac care, especially treatment for heart valve diseases through the novel minimally invasive valve replacement procedure, TAVI. The faculty comprised of Dr Susheel Kodali, Senior Cardiologist, Director – The Structural Heart & Valve Center at New York, Presbyterian/ Columbia University Medical Center, USA; Dr A Sreenivas Kumar, Sr Consultant & Director, Interventional Cardiology, Apollo Hospitals; Dr M Gokul Reddy, Sr Consultant Cardiologist, Apollo Hospitals; Dr Sanjeev Kumar, Consultant Cardiologist, Apollo Hospitals and Dr Ramakrishna J, Consultant Cardiologist, Apollo Hospitals; empowered the delegates with the finer techniques of TAVI procedure, the convenience it brings to the treating cardiologist and the enormous benefits to the patient.
As part of the collaboration between Columbia University Medical Center, USA and Apollo Hospitals, Hyderabad; Dr Susheel Kodali and Dr A. Sreenivas Kumar; treated over one hundred patients with TAVI, during the last four years.
“Owing to increasing life expectancy, we are likely to see more and more patients with aortic stenosis and other degenerative valve conditions over the years to come. All these patients will immensely benefit from the patient-friendly and minimally risky TAVI,” says Dr Kodali.
